ADIAL PHARMACEUTICALS, INC.
ADIL · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Davidson Matt: Form 4
Insider disclosure · Filed · Report period 28 Oct 2026
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q/A
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001513525 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ADIL on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 1180 Seminole Trail, Suite 495, Charlottesville, VA, 22901
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Adial Pharmaceuticals, L.L.C. (to 28 Sep 2017), ADial Pharmaceuticals, L.L.C. (to 28 Sep 2017)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields